SANGAMO THERAPEUTICS, INC.;MEDICAL RESEARCH COUNSEL
发明人:
MINCZUK, Michal,ZHANG, Lei,GAMMAGE, Payam A.
申请号：
USUS2019/023359
公开号：
WO2019/183349A1
申请日:
2019.03.21
申请国别(地区):
US
年份:
2019
代理人:
摘要：
The present disclosure is in the field of genome engineering, particularly targeted genetic modification of mitochondrial DNA (mtDNA).La présente invention concerne le domaine de l'ingénierie génomique, en particulier la modification génétique ciblée d'ADN mitochondrial (ADNmt).
